NCT07823218

Brief Summary

This study investigates the longitudinal effects of brain stimulation treatments on decision-making and reward learning. Here, we use daily assessments of reinforcement learning behavior in patients with depression who receive neuromodulation treatment to study potential associations between changes in decision-making and reward learning and changes in clinical symptoms.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
22mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Sep 2026Aug 2028

Study Start

First participant enrolled

September 1, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

September 16, 2026

Status Verified

September 1, 2026

Enrollment Period

1.9 years

First QC Date

September 10, 2026

Last Update Submit

September 10, 2026

Conditions

Keywords

Brain StimulationReinforcement LearningECTrepetitive transcranial magnetic stimulationVNStVNSDepression

Outcome Measures

Primary Outcomes (1)

  • Punishment learning rates

    The primary outcome are punishment learning rate estimates from a computational reinforcement learning model. Learning rates will be compared within and between stimulation conditions. Reinforcement learning is repeatedly measured with a bandit task with fluctuating reward probabilities (reward learning task). Reward learning behavior will be collected online over up to 60 runs, each including 150 trials.

    Assessed online up to 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

Secondary Outcomes (17)

  • Stimulation-induced mid-term changes in the backward digit span

    Assessed before the first stimulation treatment and after 4 and 8 weeks (10 minutes).

  • Correct choices in the reward learning task

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • Reward sensitivity

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • Weighting of learned values and rewards at stake (lambda)

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • Stimulation-induced mid-term changes in reward learning rates

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • +12 more secondary outcomes

Other Outcomes (3)

  • Mood state

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • Metabolic state

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

  • Motivational state

    Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).

Study Arms (5)

Electroconvulsive therapy (ECT)

Participants receive ECT as a treatment within the clinic. ECT intentionally causes a generalized seizure by passing electrical currents through the brain under anesthesia. The treatment protocol (e.g., number of treatments) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.

Transcranial magnetic stimulation (TMS)

Participants receive TMS as a treatment within the clinic. TMS is a non-invasive procedure in which a magnetic coil is used to induce electrical currents in the brain and thus influence cortex activity. The treatment protocol (e.g., number of treatments, type of TMS) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.

invasive vagus nerve stimulation (VNS)

Participants receive VNS as a treatment within the clinic. VNS is a surgical treatment in which a stimulation device is implanted that sends electrical impulses to the vagus nerve. The treatment protocol (e.g., stimulation settings) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.

transcutaneous vagus nerve stimulation (tVNS)

Participants receive tVNS as a treatment from the clinic for at home stimulation. To stimulate vagal afferents, the electrode will be placed at the cymba conchae of the right ear using a previously established conventional stimulation protocol (30s ON, 30s OFF; tVNS E device, tVNS Technologies GmbH, Erlangen, Germany). The stimulation can be applied for up to 4h per day and participants self-select stimulation time and duration based on the doctor's orders. Participants are enrolled after the treatment indication is confirmed.

Control

Participants receive an indication for a stimulation treatment within the clinic, but do not make use of it. Participants are included after treatment indication.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients in the Department of Psychiatry and Psychotherapy at the University Hospital Bonn, who receive an indication for a brain stimulation treatment (ECT, TMS, VNS, taVNS).

You may qualify if:

  • Indication for a brain stimulation treatment (ECT, TMS, VNS, taVNS) in the Department of Psychiatry and Psychotherapy at the University Hospital Bonn
  • Be able and willing to provide informed consent.

You may not qualify if:

  • Non-German speakers
  • Unclear ability to give consent to the study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn

Bonn, 53127, Germany

Location

Related Publications (16)

  • Neuser MP, Kuhnel A, Krautlein F, Teckentrup V, Svaldi J, Kroemer NB. Reliability of gamified reinforcement learning in densely sampled longitudinal assessments. PLOS Digit Health. 2023 Sep 6;2(9):e0000330. doi: 10.1371/journal.pdig.0000330. eCollection 2023 Sep.

    PMID: 37672521BACKGROUND
  • Huys QJM, Browning M. A Computational View on the Nature of Reward and Value in Anhedonia. Curr Top Behav Neurosci. 2022;58:421-441. doi: 10.1007/7854_2021_290.

    PMID: 34935117BACKGROUND
  • Kuehnel A, Zietz J, Theuer JK, Neuser MP, Kroemer NB; Dense sampling of choices links high learning rates to obesity and low reward sensitivity to binge eating; medRxiv; 2025 Jun 20

    BACKGROUND
  • Weber I, Niehaus H, Krause K, Molitor L, Peper M, Schmidt L, Hakel L, Timmermann L, Menzler K, Knake S, Oehrn CR. Trust your gut: vagal nerve stimulation in humans improves reinforcement learning. Brain Commun. 2021 Mar 14;3(2):fcab039. doi: 10.1093/braincomms/fcab039. eCollection 2021.

    PMID: 33928247BACKGROUND
  • Trapp NT, Purgianto A, Taylor JJ, Singh MK, Oberman LM, Mickey BJ, Youssef NA, Solzbacher D, Zebley B, Cabrera LY, Conroy S, Cristancho M, Richards JR, Flood MJ, Barbour T, Blumberger DM, Taylor SF, Feifel D, Reti IM, McClintock SM, Lisanby SH, Husain MM; National Network of Depression Centers Neuromodulation Task Group. Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2025 Feb;170:206-233. doi: 10.1016/j.clinph.2024.12.015. Epub 2024 Dec 19.

    PMID: 39756350BACKGROUND
  • Subramanian S, Lopez R, Zorumski CF, Cristancho P. Electroconvulsive therapy in treatment resistant depression. J Neurol Sci. 2022 Mar 15;434:120095. doi: 10.1016/j.jns.2021.120095. Epub 2021 Dec 18.

    PMID: 34979372BACKGROUND
  • Pike AC, Robinson OJ. Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022 Apr 1;79(4):313-322. doi: 10.1001/jamapsychiatry.2022.0051.

    PMID: 35234834BACKGROUND
  • Landry M, Moreno A, Patry S, Potvin S, Lemasson M. Current Practices of Electroconvulsive Therapy in Mental Disorders: A Systematic Review and Meta-Analysis of Short and Long-Term Cognitive Effects. J ECT. 2021 Jun 1;37(2):119-127. doi: 10.1097/YCT.0000000000000723.

    PMID: 33009218BACKGROUND
  • Kuhnel A, Teckentrup V, Neuser MP, Huys QJM, Burrasch C, Walter M, Kroemer NB. Stimulation of the vagus nerve reduces learning in a go/no-go reinforcement learning task. Eur Neuropsychopharmacol. 2020 Jun;35:17-29. doi: 10.1016/j.euroneuro.2020.03.023. Epub 2020 May 11.

    PMID: 32404279BACKGROUND
  • Kamel LY, Xiong W, Gott BM, Kumar A, Conway CR. Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression. J Neurol Sci. 2022 Mar 15;434:120171. doi: 10.1016/j.jns.2022.120171. Epub 2022 Jan 29.

    PMID: 35158102BACKGROUND
  • Hewitt SRC, Norbury A, Huys QJM, Hauser TU. Day-to-day fluctuations in motivation drive effort-based decision-making. Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2417964122. doi: 10.1073/pnas.2417964122. Epub 2025 Mar 17.

    PMID: 40096607BACKGROUND
  • Ferstl M, Kuhnel A, Klaus J, Lin WM, Kroemer NB. Non-invasive vagus nerve stimulation conditions increased invigoration and wanting in depression. Compr Psychiatry. 2024 Jul;132:152488. doi: 10.1016/j.comppsych.2024.152488. Epub 2024 Apr 16.

    PMID: 38657358BACKGROUND
  • Espinoza RT, Kellner CH. Electroconvulsive Therapy. N Engl J Med. 2022 Feb 17;386(7):667-672. doi: 10.1056/NEJMra2034954. No abstract available.

    PMID: 35172057BACKGROUND
  • Conroy SK, Holtzheimer PE. Neuromodulation Strategies for the Treatment of Depression. Am J Psychiatry. 2021 Dec;178(12):1082-1088. doi: 10.1176/appi.ajp.2021.21101034.

    PMID: 34855452BACKGROUND
  • Biernacki K, Myers CE, Cole S, Cavanagh JF, Baker TE. Prefrontal transcranial magnetic stimulation boosts response vigour during reinforcement learning in healthy adults. Eur J Neurosci. 2023 Feb;57(4):680-691. doi: 10.1111/ejn.15905. Epub 2022 Dec 30.

    PMID: 36550631BACKGROUND
  • Amlung M, Marsden E, Holshausen K, Morris V, Patel H, Vedelago L, Naish KR, Reed DD, McCabe RE. Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders: A Meta-analysis. JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186. doi: 10.1001/jamapsychiatry.2019.2102.

    PMID: 31461131BACKGROUND

MeSH Terms

Conditions

DepressionDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Nils B Kroemer, Prof. Dr.

    Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nils B Kroemer, Prof. Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. rer. nat.

Study Record Dates

First Submitted

September 10, 2026

First Posted

September 16, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

September 16, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

After the publication of the key results of the study, anonymized data will be made publicly available (e.g., at osf.org).

Time Frame
Anonymized data will be shared upon publication of the results
Access Criteria
Until the data is publicly available, researchers may contact the lead PI to gain access.
More information

Locations